Neither approach is inherently safer
A 2025 study published in JMIR Formative Research found that active subscribers on Second Natures GLP-1-supported programme lost an average of 19.1% of body weight at 12 months, with 77.7% achieving at least 10% weight loss
[It means] being able to get patients, who may have had to go through a stepwise approach or may not previously have qualified, those medications. 1 Semaglutides ability to provide weight loss and kidney improvements could influence patients preference for the drug over other agents that gain multiple indications in the future, explained Kaitlin ORourke, PharmD, BCPS, an advanced practice clinical pharmacist at Brigham and Womens Hospital in Boston, Massachusetts
A representative for Lilly replied emphasizing the companys commitment to safety, and encouraged patients to report side effects to their healthcare provider
For plans that cover medications for weight loss, care management strategies, including member education, help optimize investment in weight loss medications and support patients in their journey towards better health
This difference compounds over time, making muscle mass one of the most important factors in long-term weight management